RU2015114205A - Photosensitizer gel for photodynamic therapy - Google Patents

Photosensitizer gel for photodynamic therapy Download PDF

Info

Publication number
RU2015114205A
RU2015114205A RU2015114205A RU2015114205A RU2015114205A RU 2015114205 A RU2015114205 A RU 2015114205A RU 2015114205 A RU2015114205 A RU 2015114205A RU 2015114205 A RU2015114205 A RU 2015114205A RU 2015114205 A RU2015114205 A RU 2015114205A
Authority
RU
Russia
Prior art keywords
photodynamic therapy
photosensitizer
gel
phosphor
molecular weight
Prior art date
Application number
RU2015114205A
Other languages
Russian (ru)
Other versions
RU2606834C2 (en
Inventor
Андрей Владимирович Батомункуев
Вячеслав Владимирович Ашмаров
Сергей Сергеевич Дауэ
Original Assignee
Общество с ограниченной ответственностью "РЕВИКСАН" (ООО "РЕВИКСАН")
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "РЕВИКСАН" (ООО "РЕВИКСАН") filed Critical Общество с ограниченной ответственностью "РЕВИКСАН" (ООО "РЕВИКСАН")
Priority to RU2015114205A priority Critical patent/RU2606834C2/en
Publication of RU2015114205A publication Critical patent/RU2015114205A/en
Application granted granted Critical
Publication of RU2606834C2 publication Critical patent/RU2606834C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Radiation-Therapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Композиция для проведения фотодинамической терапии, включающая фотосенсибилизатор и гель, отличающаяся тем, что она дополнительно содержит низкомолекулярный люминофор и/или полимерный люминофор, при следующем соотношении компонентов, мас. %:A composition for conducting photodynamic therapy, including a photosensitizer and a gel, characterized in that it further comprises a low molecular weight phosphor and / or polymer phosphor, in the following ratio, wt. %:

Claims (1)

Композиция для проведения фотодинамической терапии, включающая фотосенсибилизатор и гель, отличающаяся тем, что она дополнительно содержит низкомолекулярный люминофор и/или полимерный люминофор, при следующем соотношении компонентов, мас. %:A composition for conducting photodynamic therapy, including a photosensitizer and a gel, characterized in that it further comprises a low molecular weight phosphor and / or polymer phosphor, in the following ratio, wt. %: фотосенсибилизаторphotosensitizer 0,01-100.01-10 низкомолекулярный люминофор и/илиlow molecular weight phosphor and / or   полимерный люминофорpolymer phosphor 0,001-0,50.001-0.5 гельgel остальноеrest
RU2015114205A 2015-04-17 2015-04-17 Gel-photosensitizer for photodynamic therapy RU2606834C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2015114205A RU2606834C2 (en) 2015-04-17 2015-04-17 Gel-photosensitizer for photodynamic therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2015114205A RU2606834C2 (en) 2015-04-17 2015-04-17 Gel-photosensitizer for photodynamic therapy

Publications (2)

Publication Number Publication Date
RU2015114205A true RU2015114205A (en) 2016-11-10
RU2606834C2 RU2606834C2 (en) 2017-01-10

Family

ID=57267673

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015114205A RU2606834C2 (en) 2015-04-17 2015-04-17 Gel-photosensitizer for photodynamic therapy

Country Status (1)

Country Link
RU (1) RU2606834C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2728108C1 (en) * 2019-11-27 2020-07-28 Андрей Владимирович Батомункуев Method for photodynamic therapy of oral diseases and dental gel-photosensitizer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2820041B3 (en) * 2001-01-29 2003-04-11 Nero Didier Rege LUMINOPHORE PRODUCT FOR IMPROVING DYNAMIC PHOTO THERAPY AND AVOIDING SKIN PHOTOSENSITIZATION
US20050059731A1 (en) * 2003-09-16 2005-03-17 Ceramoptec Industries, Inc. Erythrosin-based antimicrobial photodynamic therapy compound and its use
RU2379026C2 (en) * 2008-04-15 2010-01-20 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Composition for fluorescent diagnostics and photodynamic therapy

Also Published As

Publication number Publication date
RU2606834C2 (en) 2017-01-10

Similar Documents

Publication Publication Date Title
CO2020003478A2 (en) Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and their uses
EA201991555A1 (en) COMPOSITIONS AND METHODS FOR STRENGTHENING OR INCREASING PRODUCTS IFN I TYPE
CR20170036A (en) INHIBITORS OF PROTEIN QUINASA C AND METHODS OF USE
MX2021001612A (en) Compounds useful in hiv therapy.
CO2021006480A2 (en) Rip1 inhibitors
RU2015114205A (en) Photosensitizer gel for photodynamic therapy
RU2015115143A (en) Wound healing gel for external use
RU2010146997A (en) PHARMACEUTICAL COMPOSITION CONTAINING SILDENAFIL AND / OR ALPROSTADIL, MINOXIDIL AND / OR EUFILLIN, TESTOSTERON AND / OR YOCHIMBIN AND LIPOSOMES FOR LOCAL USE
RU2009122296A (en) IMMUNOMETABOLIC ANTHELMINTIC DRUG
RU2014148029A (en) Hair Growth Suppressant
RU2013135821A (en) Means for the treatment of purulent-inflammatory processes of soft tissues and mucous membranes
RU2014104457A (en) LIQUID POLISHING PASTE
RU2012116371A (en) WELL KILLING LIQUID
RU2013143524A (en) PHARMACEUTICAL COMPOSITION HAVING ANTIVYPOXIC, NEUROPROTECTOR AND ANTIMNESTIC ACTIVITY AND INCREASING PHYSICAL OPERATION
RU2013130140A (en) DRUG FOR TREATMENT OF NECROBACTERIOSIS OF NORTHERN DEER
RU2013135817A (en) Means for the treatment of purulent-inflammatory processes of soft tissues and mucous membranes
RU2014150258A (en) AGENT WITH IMMUNOMODULATING PROPERTIES FOR PREVENTION OF ATHEROSCLEROSIS
RU2013118518A (en) COMPOSITION FOR ELECTROLYTE-PLASMA NITROCEMENT
RU2011133725A (en) COMPOSITION FOR DESTRUCTION OF A cross-linked gel based on guar gum
RU2015105061A (en) DERMATOLOGICAL COMPOSITION
RU2013118054A (en) DRILLING MILL
RU2013141484A (en) BIOLOGICALLY ACTIVE DERIVATIVES OF ALLOPHERON-1
RU2014146551A (en) Polymer composition
RU2013133476A (en) IMMUNOMETABOLIC COMPOSITION WITH ANTIMICROBIAL ACTIVITY
RU2013118038A (en) COMPOSITION BASED ON DIHYDROQUERCERETINE INCLUDED IN PHOSPHOLIPID NANOPARTICLES

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20180418

NF4A Reinstatement of patent

Effective date: 20210428